These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3134721)

  • 41. [The results of combined radiotherapy of cancer of the corpus uteri].
    Tsybulina LI; Krauz VS
    Med Radiol (Mosk); 1984 Jun; 29(6):29-32. PubMed ID: 6738323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effectiveness of combined radiotherapy in patients with cancer of the corpus uteri].
    Kholin VV; Stoliarova IV; Zharinov GM
    Vopr Onkol; 1987; 33(10):78-83. PubMed ID: 3686912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Can high voltage technics partly compensate for radium treatment in uterine cancer].
    Löfqvist I; Johansson M; Nyström C
    Nord Med; 1971 Oct; 85(43):1250. PubMed ID: 5000741
    [No Abstract]   [Full Text] [Related]  

  • 45. [Complications in supervoltage therapy of uterine malignancies].
    Kob D; Arndt J; Schuberth K; Pohl E
    Zentralbl Gynakol; 1972 Oct; 14(42):1377-87. PubMed ID: 4629603
    [No Abstract]   [Full Text] [Related]  

  • 46. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
    Tanaka E; Oh RJ; Yamada Y; Shiomi H; Nakamura S; Shimamoto S; Teshima T; Inoue T; Inoue T
    Brachytherapy; 2003; 2(2):85-90. PubMed ID: 15062145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Afterloading method for simulating the intrauterine packing method in case of carcinoma of the body of the uterus (author's transl)].
    Bauer M; von Fournier D; Fehrentz F; Kuttig H; zum Winkel K; Neldner F
    Strahlentherapie; 1981 Dec; 157(12):793-800. PubMed ID: 7330907
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Standards, options, and recommendations for the radiotherapy of patients with endometrial cancer. FNCLCC (National Federation of Cancer Campaign Centers) and CRLCC (Regional Cancer Campaign Centers)].
    Thomas L; Bataillard A; Brémond A; Fondrinier E; Fervers B; Achard JL; Lansac J; Bailly C; Hoffstetter S; Basuyau JP; d'Anjou J; Descamps P; Farsi F; Guastalla JP; Laffargue F; Rodier JF; Vincent P; Pigneux J
    Cancer Radiother; 2001 Apr; 5(2):163-92. PubMed ID: 11355582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect control of HDR afterloading radiation in uterine cancer by NMR imaging with and without GD-DTPA.
    Roth G
    Sonderb Strahlenther Onkol; 1988; 82():48-50. PubMed ID: 3394002
    [No Abstract]   [Full Text] [Related]  

  • 50. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [High energy radiotherapy as compared to conventional radiotherapy].
    Vahrson H
    Zentralbl Gynakol; 1971 Oct; 93(42):1447-56. PubMed ID: 5004287
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical value of the Nominal Standard Dose (NSD) and Time-Dose Factor (TDF) in the evaluation of probability of cure and risk of complications in patients with cervical cancer treated with radium].
    Rattka P; Maciejewski B
    Pol Przegl Radiol Med Nukl; 1982; 46(5-6):281-6. PubMed ID: 7170254
    [No Abstract]   [Full Text] [Related]  

  • 53. [Value and importance of intracavitary therapy in cervix carcinoma].
    Frischkorn R
    Strahlenther Onkol; 1986 Jun; 162(6):361-7. PubMed ID: 3738737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-dose-rate brachytherapy as the primary treatment of medically inoperable stage I-II endometrial carcinoma.
    Nguyen C; Souhami L; Roman TN; Clark BG
    Gynecol Oncol; 1995 Dec; 59(3):370-5. PubMed ID: 8522257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Optimization of intracavity irradiation in the treatment of cancer of the corpus uteri using high-activity sources].
    Tsybulina LI; Ivanov VK; Krauz VS; Mardynskiĭ IuS; Bendiu SG
    Med Radiol (Mosk); 1985 Sep; 30(9):24-7. PubMed ID: 4046775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The association of curietherapy and surgery in the treatment of endometrium carcinoma.
    Debois JM
    Strahlenther Onkol; 1986 Sep; 162(9):540-8. PubMed ID: 3764678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Present status of brachytherapy, especially HDR afterloading in Japan.
    Morita K; Uchiyama Y
    Sonderb Strahlenther Onkol; 1988; 82():16-21. PubMed ID: 3134712
    [No Abstract]   [Full Text] [Related]  

  • 58. Experiences with interstitial HDR afterloading therapy in genital and breast cancer.
    Jacobs H
    Sonderb Strahlenther Onkol; 1988; 82():258-62. PubMed ID: 3134722
    [No Abstract]   [Full Text] [Related]  

  • 59. A prospective randomized study concerning the point A dose in high-dose rate intracavitary therapy for carcinoma of the uterine cervix. The final results.
    Chatani M; Matayoshi Y; Masaki N; Teshima T; Inoue T
    Strahlenther Onkol; 1994 Nov; 170(11):636-42. PubMed ID: 7974179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Results of primary radiotherapy for corpus carcinoma in the years 1950-1966].
    Hernuss P; Weghaupt K
    Osterr Z Erforsch Bekampf Krebskr; 1972; 27(5):313-9. PubMed ID: 4678901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.